Efficacy of automatic bolus calculator with automatic speech recognition in patients with type 1 diabetes: A randomized cross‐over trial

Foltynski, Piotr; Ładyżyński, Piotr; Pańkowska, Ewa; Mazurczak, Karolina

doi:10.1111/1753-0407.12641

Cited by 18 publications

(24 citation statements)

References 23 publications

(38 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…One study [13] used the VoiceDiab ® app, which helps users calculate the bolus insulin needed to avoid hypo and hyperglycemia by entering blood glucose data (which can be voice-entered). The app tries to help patients to increase the glycemic time-in-range, within the recommended 70-180 mg/dL.…”

Section: Apps and Mobile Phones For The Control Of Dm1mentioning

confidence: 99%

“…The app tries to help patients to increase the glycemic time-in-range, within the recommended 70-180 mg/dL. However, after the intervention, no significant changes were found in the HbA1c levels between the control group (6.98) and the intervention group (7.10) [13]. In the study with children and adolescents done by Klee et al, they found that the patients that used the app Webdia (designed for metabolic control in diabetes 1) decreased their level of HbA1c by 0.33 (±0.75), while the HbA1c level increased with the usual care 0.21 (±0.79) [14].…”

Section: Apps and Mobile Phones For The Control Of Dm1mentioning

confidence: 99%

See 1 more Smart Citation

Smartphones and Apps to Control Glycosylated Hemoglobin (HbA1c) Level in Diabetes: A Systematic Review and Meta-Analysis

Martos-Cabrera

Velando‐Soriano

Pradas‐Hernández

et al. 2020

JCM

View full text Add to dashboard Cite

Introduction: Diabetes mellitus is a chronic endocrine-metabolic disease, the evolution of which is closely related to people’s self-control of glycemic levels through nutrition, exercise, and medicines. Aim: To determine whether smartphone apps can help persons with diabetes to improve their % levels of glycosylated hemoglobin. Method: A systematic review and meta-analysis were done. ProQuest, Pubmed/Medline, and Scopus databases were used. The search equation used was “(Prevention and Control) AND Diabetes Mellitus AND Smartphones”. The inclusion criteria applied were clinical trials, conducted in 2014–2019. Results: n = 18 studies were included in the review. The studies tried different applications to monitor glycemia and support patients to improve glycosylated hemoglobin (HbA1c) levels. More than half of the studies found statistically significant differences in HbA1c in the intervention group compared with the control group. Eleven studies were included in the meta-analysis and the study sample was n = 545 for the experimental group and n = 454 for the control group. The meta-analytic estimation of the HbA1c % level means differences between intervention and control group was statistically significant in favour of the intervention group with a mean difference of –0.37 (–0.58, –0.15. 95% confidence interval). Conclusion: Smartphone apps can help people with diabetes to improve their level of HbA1c, but the clinical impact is low.

show abstract

Section: Apps and Mobile Phones For The Control Of Dm1mentioning

confidence: 99%

Section: Apps and Mobile Phones For The Control Of Dm1mentioning

confidence: 99%

Smartphones and Apps to Control Glycosylated Hemoglobin (HbA1c) Level in Diabetes: A Systematic Review and Meta-Analysis

Martos-Cabrera

Velando‐Soriano

Pradas‐Hernández

et al. 2020

JCM

View full text Add to dashboard Cite

show abstract

“…According to an analysis of Sussman et al (77), patients with insulin-treated diabetes made errors in more than half of the calculated insulin doses. Several studies reported a clear benefit (79)(80)(81)(82), whereas other authors (83-86) concluded a positive effect only in special aspects. Automated bolus calculators have been available for many years.…”

Section: Automated Bolus Calculatorsmentioning

confidence: 95%

Technology in Diabetes Treatment: Update and Future

Schiel¹,

Bambauer²,

Steveling

2018

Artificial Organs

View full text Add to dashboard Cite

Worldwide the number of people with diabetes mellitus is increasing. There are estimations that diabetes is one of the leading causes of death. The most important goals for the treatment of diabetes are self‐management of the disease and an optimal quality of diabetes control. In the therapy new technologies, like real‐time continuous interstitial glucose monitoring, continuous subcutaneous insulin infusion (CSII), electronic tools for the monitoring of therapeutic approaches, automated bolus calculators for insulin and electronic tools for education and information of patients, have become widespread and play important roles. All these efforts are related to the interaction between patients, caregivers, scientists or researchers and industry. The presentation of different aspects of new technological approaches in the present article should give more information about different technologies. However, because of the rather quickly appearance of new technologies, the presentation can only be a spotlight. Further studies are mandatory to analyze the effects and long‐term benefits of each technology and electronic device.

show abstract

“…How Important Is a Closed-Loop Artificial Pancreas? doi: 10.1111/aor.13338 applications (9). The hybrid CLAP system also needs to be notified that user performs exercises.…”

Section: Invited Editorialmentioning

confidence: 99%

“…Such a procedure is necessary in maintaining a stable glycemia course, but requires additional skills and knowledge from users. Some of them may have problems with such estimations and may use software dietary advisors available as computer or smartphone applications . The hybrid CLAP system also needs to be notified that user performs exercises.…”

mentioning

confidence: 99%

How Important Is a Closed‐Loop Artificial Pancreas?

Foltynski

2018

Artificial Organs

Self Cite

View full text Add to dashboard Cite

Efficacy of automatic bolus calculator with automatic speech recognition in patients with type 1 diabetes: A randomized cross‐over trial

Abstract: The VoiceDiab system improves postprandial glucose control without increasing the time in hyperglycemia or hypoglycemia. Therefore, it may be useful in the treatment of patients with diabetes on intensive insulin therapy.

Cited by 18 publications

References 23 publications

Smartphones and Apps to Control Glycosylated Hemoglobin (HbA1c) Level in Diabetes: A Systematic Review and Meta-Analysis

Smartphones and Apps to Control Glycosylated Hemoglobin (HbA1c) Level in Diabetes: A Systematic Review and Meta-Analysis

Technology in Diabetes Treatment: Update and Future

How Important Is a Closed‐Loop Artificial Pancreas?

Contact Info

Product

Resources

About